Activation of tumor-infiltrating macrophages by a synthetic lipid A analog (ONO-4007) and its implication in antitumor effects
- 50 Downloads
ONO-4007 is a novel synthetic analog of lipid A subunit and has been shown to exert antitumor activities on various experimental tumors with less toxicity than lipopolysaccharide. It remains unclear, however, what biological activities of this compound are relevant to its antitumor effects. We therefore investigated the activation of macrophages by ONO-4007 in vitro and in vivo and its implication in antitumor effects, using mouse MM46 mammary tumor as an experimental model. Intravenous injection of ONO-4007 produced significant therapeutic effects on this solid tumor. ONO-4007 could stimulate glycogen-elicited peritoneal macrophages in vitro, not only to produce tumor necrosis factor (TNF), but also to exert cytocidal activities against MM46 cells in vitro. Substantial TNF production was induced in tumor tissue by i. v. injection of ONO-4007, and its successive administration to tumor-bearing mice gave tumor-infiltrating macrophages a prominent in vitro tumoricidal activity and primed them for in vitro TNF secretion. These results suggest that activation of tumor-infiltrating macrophages to a direct tumoricidal state as well as to TNF secretion in tumor tissues may be at least some of the antitumor effects of this novel lipid A analog.
Key wordsONO-4007 Lipid A Antitumor effect TNF TIM
Unable to display preview. Download preview PDF.
- 4.Branellec D, Chouaib S (1991) TNF: antitumoral agent at the borderlines of immunity and inflammation. Pathol Biol (Paris) 39: 230Google Scholar
- 7.Conti P, Dempsey RA, Reale M, Barbacane RC, Panara MR, Bongrazio M, Mier JW (1991) Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumor necrosis factor and interleukin-6: effect of IL-1 receptor antagonist. Immunology 73: 450PubMedGoogle Scholar
- 8.Fulton AM (1988) Tumor-associated macrophages In: Heppner GH, Fulton AM (eds) Macrophages and cancer. CRC, Boca Raton, Fla, p 97Google Scholar
- 13.Kusama T, Soga T, Shioya E, Nakayama K, Nakajima H, Osada Y, Ono Y, Kusumoto S, Shiba T (1990) Synthesis and antitumor activity of lipid A analogs having a phosphonooxyethyl group with α- or β-configuration at position 1. Chem Pharmacol Bull 38: 3366Google Scholar
- 15.Mizuno D (1988) Endogenous and exogenous tumor necrosis factor therapy: EET therapy. In: Bonavida B, Gifford GE, Kirchner H, Old LJ (eds) Tumor necrosis factor/cachectin and related cytokines. Karger, Basel, p 210Google Scholar
- 16.Morrison DC, Ryan JL (1983) Bacterial endotoxin and host immune response. Adv Immunol 28: 293Google Scholar
- 18.Nishizawa T, Okutomi T, Inagawa H, Morikawa A, Oshima H, Soma G, Mizuno D (1991) Intratumoral tumor necrosis factor induction in tumor-bearing mice by exogenous/endogenous tumor necrosis factor therapy as compared with systemic administration of various biologic response modifiers. Mol Biother 3: 224PubMedGoogle Scholar
- 20.Ogawa Y, Fujishima Y, Ishida H, Kiso M, Hasegawa A (1991) Synthesis of a novel series of 4-O-phosphono-d-glucosamine derivatives (lipid A subunit analogs) carrying the C-branched 2-tetradecylhexadexananoyl group. Carbohydr Res 220: 155Google Scholar
- 26.Shimizu T, Ohtsuka Y, Yanagihara Y, Akamatsu S, Ikeda K, Achiwa K (1992) Biological activity of chemically synthesized core sugar linked lipid A analog, heptose-(alpha-1–5)-2-keto-3-deoxyocturonic acid-(alpha-2–6) 2, 3-diacyloxyacyl-glucosamine-4-phosphate. Int J Immunopharmacol 14: 221PubMedGoogle Scholar
- 27.Somlyo B, Csanky E, Shi XM, Zhang YL, Kivats E, Boma-Liptak E, Nowotny AM, Tripodi D, Nowotny A (1992) Molecular requirements of endotoxin (ET) actions: changes in the immune adjuvant, TNF liberating and toxix properties of endotoxin during alkaline hydrolysis. Int J Immunopharmacol 14: 131PubMedGoogle Scholar
- 32.Yamazaki M, Esumi-Kurisu M, Mizuno D (1982) Modulation and induction of mediator-dependent tumor lysis mediated by macrophages. In: Mizuno D, Cohn ZA, Takeya K, Ishida N (eds) Selfdefense mechanisms. Elsevier Biomedical. New York, p 295Google Scholar